Cellebrite DI Ltd. (CLBT) Earnings History
Profitable7 years of earnings data (2019–2025) · Positive TTM net income
Loading earnings history...
Cellebrite DI Ltd. (CLBT) Earnings Overview
As of June 22, 2026, Cellebrite DI Ltd. (CLBT) reported trailing twelve-month net income of $72M, reflecting +123.0% year-over-year growth. The company earned $0.29 per diluted share over the past four quarters, with a net profit margin of 16.5%.
Looking at the long-term picture, CLBT's historical earnings data spans multiple years. The company achieved its highest annual net income of $121M in fiscal 2022.
Cellebrite DI Ltd. maintains industry-leading profitability with a gross margin of 84.2%, operating margin of 14.0%, and net margin of 16.5%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including AXON ($206M net income, 4.5% margin), VRNS (-$137M net income, -20.7% margin), OSPN ($70M net income, 30.0% margin), CLBT has outperformed on profitability metrics. Compare CLBT vs AXON →
CLBT Earnings vs Peers
Earnings metrics vs comparable public companies
CLBT Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $78M | +127.7% | $66M | $0.31 | 16.5% | 14.0% |
| 2024 | -$283M | -249.0% | $57M | $-1.35 | -70.5% | 14.2% |
| 2023 | -$81M | -167.1% | $33M | $-0.43 | -24.9% | 10.2% |
| 2022 | $121M | +69.2% | $1M | $0.59 | 44.6% | 0.4% |
| 2021 | $71M | +1135.0% | $14M | $0.44 | 29.0% | 5.6% |
| 2020 | $6M | +408.2% | $9M | $-0.05 | 3.0% | 4.7% |
| 2019 | -$2M | - | -$2M | $-0.05 | -1.1% | -0.9% |
Download Data
Export CLBT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CLBT — Frequently Asked Questions
Quick answers to the most common questions about buying CLBT stock.
What is CLBT earnings per share (EPS)?
CLBT trailing twelve-month (TTM) diluted EPS is $0.29, reflecting +123.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is Cellebrite DI Ltd.'s net income?
Cellebrite DI Ltd. (CLBT) trailing twelve-month net income is $72M as of 2025. Earnings grew +123.0% year-over-year.
Is CLBT profitable?
Yes, CLBT is profitable with a TTM net income of $72M and a net profit margin of +16.5%.
What is CLBT's earnings growth rate?
CLBT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: -19.3%, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are CLBT's profit margins?
Cellebrite DI Ltd. net profit margin is +16.5%, operating margin is +14.0%, and gross margin is +84.2%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +19.1%.
Is CLBT growing earnings?
Yes, CLBT earnings are accelerating — EPS growth of +123.0% exceeds the 5-year CAGR of N/A. TTM net income reached $72M. Earnings momentum is strengthening.
What was CLBT's best earnings year?
Cellebrite DI Ltd.'s highest annual net income on record is $121M, achieved in fiscal year 2022. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were CLBT's earnings last quarter?
CLBT's most recent reported quarter was Q1 2026. Net income was $11M with diluted EPS of $0.04. For a full breakdown of all quarters, see the quarterly earnings table on this page.